BR0010525A - cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase - Google Patents

cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase

Info

Publication number
BR0010525A
BR0010525A BR0010525-2A BR0010525A BR0010525A BR 0010525 A BR0010525 A BR 0010525A BR 0010525 A BR0010525 A BR 0010525A BR 0010525 A BR0010525 A BR 0010525A
Authority
BR
Brazil
Prior art keywords
cyclohexene
neuraminidase
carboxylic acid
compounds
neuraminidase inhibitors
Prior art date
Application number
BR0010525-2A
Other languages
English (en)
Inventor
Clarence J Maring
Vincent L Giranda
Dale J Kempf
Vincent S Stoll
Minghua Sun
Chen Zhao
Yu Gui Gu
Stephen Hanessian
Kent D Stewart
Gary T Wang
Jianchio Wang
Darold L Madigan
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0010525A publication Critical patent/BR0010525A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"áCIDO 1-CICLO-HEXENO-1-CARBOXìLICO E 1-CICLO-HEXENO-1-CARBOXILATOS COMO INIBIDORES DE NEURAMINIDASE". A presente invenção fornece compostos das fórmulas Ia e Ib ou um seu sal, pró-medicamento, ou éster de uso farmacêutico, úteis para inibir enzimas neuraminidase de microorganismos causadores de doenças, especialmente neuraminidase de influenza, formulações farmacêuticas que contêm os mesmas, processos e intermediários para preparar esses compostos, bem como métodos para usar os ditos compostos, inclusive para prevenir e tratar doenças causadas por microorganismos que têm a dita enzima neuraminidase.
BR0010525-2A 1999-10-19 2000-09-22 cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase BR0010525A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42107799A 1999-10-19 1999-10-19
US42809399A 1999-10-27 1999-10-27
PCT/US2000/026119 WO2001028981A1 (en) 1999-10-19 2000-09-22 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors

Publications (1)

Publication Number Publication Date
BR0010525A true BR0010525A (pt) 2002-11-26

Family

ID=27025098

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010525-2A BR0010525A (pt) 1999-10-19 2000-09-22 cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase

Country Status (3)

Country Link
AU (1) AU7608100A (pt)
BR (1) BR0010525A (pt)
WO (1) WO2001028981A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403824B2 (en) * 2000-02-22 2002-06-11 Hoffmann-La Roche Inc. Process for the preparation for 4,5-diamino shikimic acid derivatives
AU2002333601A1 (en) 2001-09-14 2003-04-01 Asm America, Inc. Metal nitride deposition by ald using gettering reactant
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
US20120010254A1 (en) * 2008-12-30 2012-01-12 Simon Fraser University Compounds and methods for treatment of influenza
CN111470999A (zh) * 2020-05-18 2020-07-31 中山万汉制药有限公司 N-环己烯基-脂肪酰胺类化合物及其制备方法、组合物与用途
CN116354869A (zh) * 2023-02-13 2023-06-30 北京恒创星远医药科技有限公司 一种环己烯类抗病毒化合物的合成工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
WO1999014185A1 (en) * 1997-09-17 1999-03-25 Gilead Sciences, Inc. Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
TW480247B (en) * 1997-12-12 2002-03-21 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
AU7608100A (en) 2001-04-30
WO2001028981A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
BR0010555A (pt) Inibidores de neuraminidases
CY1111170T1 (el) Ενωσεις διαρυλ αιθερα ουριας
FI942423A (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BR0312999A (pt) Compostos, composições farmacêticas, método para aumentar a cognição, de tratamento, de inibição da atividade de enzima pde4 em um paciente
BRPI0414856A (pt) imidazoquinolinas alcóxi-substituìdas
BR0009167A (pt) Inibidores de enzima impdh
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ES2282685T3 (es) Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer.
BR0215429A (pt) Composto de fórmula i e seus usos, métodos de inibição da atividade e método de inibição da ativação de um receptor de monoamina, métodos de tratamento, método de identificação de polimorfismo genético e método de identificação de paciente
PE20070541A1 (es) Compuestos y composiciones que comprenden isoindol-imidas
ES2194501T3 (es) Derivados de amidinas, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
MA29856B1 (fr) Derives de diacylindazole en tant qu'inhibiteurs de lipases et de phospholipases
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
BR112012011072A2 (pt) inibidores de n1-pirazolospirocetona acetil-coa carboxilase
BRPI0408990A (pt) derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase
BRPI0415683A (pt) inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
HN2003000243A (es) Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
BR0314299A (pt) Derivados de pirrolidona como inibidores de mao-b
BR0211118A (pt) Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
BRPI0410316A (pt) composto, composição farmacêutica, uso dos compostos, e, método de tratamento de distúrbios mediados por vr1 e para o tratamento de distúrbios de dores

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired